Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-15, Stock:JNJ, The news for the past five days is as follows:
2019-01-08: NEWS1: Here&apos;s What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018.NEWS2: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS3: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS4: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS5: Latest trial in J&J talc litigations gets under way in California.NEWS6: Albany region cities sue pharmaceutical companies over opioid epidemic.NEWS7: Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Latest trial in J&J talc litigations gets under way in California.
2019-01-09: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon.NEWS3: Karyopharm Files MAA for Myeloma Candidate Selinexor in EU.NEWS4: Karyopharm Files MAA for Myeloma Candidate Selinexor in EU.NEWS5: Why Johnson & Johnson Stock Fell 12% in December.NEWS6: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS7: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS8: Karyopharm Files MAA for Myeloma Candidate Selinexor in EU.NEWS9: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS10: Does Eli Lilly&apos;s $8 Billion Splurge Make Array BioPharma a Buy Now?.NEWS11: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS12: Innovation Puts Medtronic in the Lead.NEWS13: Why Johnson & Johnson May Not Have to Pay Its $4.7 Billion Court Verdict.NEWS14: Japan Approves Amgen/UCB's Osteoporosis Drug - Will U.S. Follow Suit?.NEWS15: Japan Approves Amgen/UCB's Osteoporosis Drug - Will U.S. Follow Suit?.NEWS16: Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018.NEWS17: Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018.
2019-01-10: NEWS1: Johnson & Johnson raises U.S. prices on around two dozen drugs.NEWS2: J&J raises U.S. prices on around two dozen drugs.NEWS3: Doctors: Pelvic mesh lawsuits by 4 states are ill-advised.NEWS4: 20 Women Set To Dominate The International Cannabis Space In 2019.NEWS5: Notable ETF Inflow Detected - IVW, MSFT, V, JNJ.NEWS6: Notable ETF Inflow Detected - IVW, MSFT, V, JNJ.NEWS7: Physicians criticize state lawsuits over pelvic mesh.NEWS8: Dr. Paul Janssen Award for Biomedical Research Issues 2019 Call for Nominations to Celebrate Champions of Science.NEWS9: Health Care Sector Update for 01/10/2019:  PRPO,CGIX, PHG, JNJ, PFE, MRK, ABT, AMGN.NEWS10: Health Care Sector Update for 01/10/2019:  PRPO,CGIX, PHG, JNJ, PFE, MRK, ABT, AMGN.NEWS11: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS12: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.
2019-01-11: NEWS1: Johnson & Johnson Recommends Rejection Of Below-Market "Mini-Tender" Offer By Peer & Peri LLC.NEWS2: Why This Group Is 'An Attractive Destination For Investors' In 2019.NEWS3: Why This IBD Stock Of The Day Broke Out Despite Biotech Turbulence.NEWS4: J&J raises prices on around two dozen drugs.NEWS5: WW downgraded, Google’s board faces lawsuits, J&J hikes some prices.NEWS6: Health Care Sector Update for 01/11/2019: TLRY, ADXS, APHA, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 01/11/2019: TLRY, ADXS, APHA, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 14, 2019.NEWS9: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 14, 2019.NEWS10: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS11: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS12: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.NEWS13: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.NEWS14: Johnson & Johnson Announces completion of Offer for Ci:z Holdings Co., Ltd..NEWS15: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.NEWS16: Stocks - Apple, Starbucks Fall in Premarket, Activision Tumbles, Netflix Gains.NEWS17: Johnson & Johnson Issues Update On Offer For Ci:z Holdings - Quick Facts.NEWS18: Johnson & Johnson Issues Update On Offer For Ci:z Holdings - Quick Facts.NEWS19: Surgeons fear pelvic mesh lawsuits will spook patients.NEWS20: Surgeons fear pelvic mesh lawsuits will spook patients.
2019-01-14: NEWS1: Is Teva Pharmaceutical Industries Limited Stock a Bargain?.NEWS2: U.S. lawmaker launches investigation into pharma drug pricing.NEWS3: A Look at Dow ETF Ahead of Q4 Earnings.NEWS4: A Look at Dow ETF Ahead of Q4 Earnings.NEWS5: House Dems announce sweeping investigation of drug pricing.NEWS6: House Dems announce sweeping investigation of drug pricing.NEWS7: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS8: QUAL, BTAL: Big ETF Inflows.NEWS9: QUAL, BTAL: Big ETF Inflows.NEWS10: A Look at Dow ETF Ahead of Q4 Earnings.NEWS11: Health Care Sector Update for 01/14/2019: MBOT, VRNA, ASLN, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Health Care Sector Update for 01/14/2019: MBOT, VRNA, ASLN, JNJ, PFE, MRK, ABT, AMGN.

Answer: Rise